iBio, Inc. (IBIO) Cash Flow Statement

The divergence between net losses and operating cash flow suggests that accounting adjustments, such as stock-based compensation and depreciation, are masking the true extent of the company's cash-based operational deficits. Investors should monitor whether this gap narrows as the company attempts to scale, though current figures indicate that cash outflows remain tightly coupled to the underlying net losses.

The persistent negative FCF trajectory highlights a business model that is heavily reliant on external financing to cover its high fixed-cost base. Without a significant increase in revenue or a drastic reduction in operating expenses, the current cash burn rate appears to be an existential constraint on the company's long-term viability.

This volatility suggests that the company lacks a predictable cash conversion cycle, which complicates liquidity management. The frequent swings in working capital may indicate timing mismatches between project milestones and cash collections, further exacerbating the pressure on the company's limited cash reserves.